Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1996-06-24
2000-03-07
Mach, D. Margaret M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514627, 514642, 514643, A61K 3114, A61K 3116, A61K 3174
Patent
active
060341297
ABSTRACT:
A method for treating a microbial infection in a mammal, such as a human, comprising treating the mammal with a therapeutically effective amount of a polymer comprising an amino group or an ammonium group attached to the polymer backbone via an aliphatic spacer group. The polymer can be a homopolymer or a copolymer. In one embodiment, the polymer is a copolymer comprising a monomer having a pendant ammonium group and a hydrophobic monomer.
REFERENCES:
patent: 3923973 (1975-12-01), Green et al.
patent: 3929990 (1975-12-01), Green et al.
patent: 3929991 (1975-12-01), Steward et al.
patent: 3961042 (1976-06-01), Green et al.
patent: 4005193 (1977-01-01), Green et al.
patent: 4025617 (1977-05-01), Green et al.
patent: 4026945 (1977-05-01), Green et al.
patent: 4035480 (1977-07-01), Green et al.
patent: 4113709 (1978-09-01), Quinlan
patent: 4166846 (1979-09-01), Shigematsu et al.
patent: 4206295 (1980-06-01), Wagner et al.
patent: 4217429 (1980-08-01), Wagner et al.
patent: 4379137 (1983-04-01), Ehlers et al.
patent: 4407791 (1983-10-01), Stark
patent: 4532128 (1985-07-01), Sheldon et al.
patent: 4604404 (1986-08-01), Munson, Jr. et al.
patent: 4621120 (1986-11-01), Hollister
patent: 4826924 (1989-05-01), Kourai et al.
patent: 4843130 (1989-06-01), Kourai et al.
patent: 4960590 (1990-10-01), Hollis et al.
patent: 5104649 (1992-04-01), Jansson et al.
patent: 5142010 (1992-08-01), Olstein
patent: 5149524 (1992-09-01), Sherba
patent: 5208016 (1993-05-01), Ohmae et al.
patent: 5209922 (1993-05-01), Merianos et al.
patent: 5242684 (1993-09-01), Merianos
patent: 5298242 (1994-03-01), Vanlerberghe et al.
patent: 5300287 (1994-04-01), Park
patent: 5348738 (1994-09-01), Takatsuka et al.
patent: 5358688 (1994-10-01), Robertson
patent: 5536494 (1996-07-01), Park
Mammen, M., et al., "Effective Inhibitors of Hemagglutination by Influenza Virus Synthesized from Polymers Having Active Ester Groups. Insight into Mechanism of Inhibition," J. Med. Chem. (38):4179-4190 (1995).
Zlochevskaya, I.V., et al., "Effect of Polyethyleneimine on Certain Fungi," Mosk. Univ. Biol. Sci. Bull. 30(3-4):49-52 (1975).
Zalesov, V.S., et al., "Study of the Toxicity Physiological Effect and Antibacterial Activity of Polyethyleneimine," Nauchn. Tr. Permsk. Farm. Instit. (4):31-35 (1971). Abstract.
Tashiro, T., "Removal of Escherichia coli from Water by Systems Based on Insoluble Polystyrene-Poly (ethylene Glycol)s, -Polyethylenimines, and -Polyethylenepolyamines Quaternized," J. Polymer Sci. (34):1369-1377 (1991).
Haynie, S. L., et al., "Antimicrobial Activities of Amphiphilic Peptides Covalently Bonded to a Water-Insoluble Resin", Antimicrob. Agents Chemotherapy, 39(2): 301-307 (1995).
Maloy, W. L. and Kari, U. P., "Structure-Activity Studies on Magainins and Other Host Defense Peptides", Biopolymers (Peptide Science) 37: 105-122 (1995).
Arrowood, M. J., et al., "Hemolytic Properties of Lytic Peptides Active Against the Sporozoites of Cryptosporidium parvum", J. Protozool. 38(6): 161S-163S (1991).
Holmes-Farley Stephen Randall
Mandeville, III W. Harry
Neenan Thomas X.
GelTex Pharmaceuticals Inc.
M. Mach D. Margaret
LandOfFree
Ionic polymers as anti-infective agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ionic polymers as anti-infective agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ionic polymers as anti-infective agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-363707